What Biomarin Pharmaceutical Inc. pays on H-1B filings

Biomarin Pharmaceutical Inc. filed 30 certified H-1B LCAs in FY2025-FY2026. Each one states the wage the employer will pay for a role at a worksite. Grouped by title below: what the employer stated, not what any one person earned.

FY2026 so far · 7 LCAsFY2025 · 23 LCAs

Stated wages by title

TitleLCAsYearTypical rangeMedian
Research Associate4FY2026 so far$94,432 to $142,400$103,491

Typical range is the middle half of that year's filings, or the full span when there are fewer than four. LCA counts cover FY2025-FY2026.

Filings by fiscal year

Fiscal yearCertified LCAs
FY2026 (October to June)7
FY202523

By prevailing-wage level

LevelLCAsMedian stated wage
Level I (entry)5$90,251
Level II (qualified)11$112,882
Level III (experienced)7$131,560
Level IV (fully competent)5$150,010
No level stated2$162,565

DOL sets four prevailing-wage levels for each job and place, from entry (I) to fully competent (IV). The level is the employer's own classification of the position.

Top worksites

WorksiteLCAsMedian stated wage
San Rafael, CA14$129,144
Novato, CA5$94,432
Aubrey, TX1$95,638
Charlotte, NC1$148,512
Chicago, IL1$150,010
Rancho Cordova, CA1$148,491
Sugar Hill, GA1$111,600
West Hills, CA1$164,798

Looking at Biomarin Pharmaceutical Inc.?

Nyanza shows these filings next to any posting you check, with the employer's H-1B approval history, so you can ask the right questions early.